Reduction in pain intensity · septal surgery
1 finding from 1 review
Pain intensity 24 (± 12) hours following surgery · septal surgery
1 finding from 1 review
Health‐related quality of life (HRQL) · chronic rhinosinusitis
Topical antifungal may leads to lower heath‐related quality of life (HRQL) compared with placebo/no treatment (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Adverse effects ‐ hepatic toxicity · chronic rhinosinusitis
Systemic antifungal showed no clear difference in adverse effects ‐ hepatic toxicity compared with placebo/no treatment (low certainty).
1 finding from 1 review
RR 3.35 [0.14, 78.6]
Studies not reported
Low
Gastrointestinal adverse events · chronic rhinosinusitis
Systemic antifungal showed no clear difference in adverse effects ‐ gastrointestinal disturbances compared with placebo/no treatment (low certainty).
1 finding from 1 review
RR 0.37 [0.04, 3.36]
Studies not reported
Low
Allergic adverse events · chronic rhinosinusitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Generic quality of life measures · chronic rhinosinusitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease severity score · chronic rhinosinusitis
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Generic HRQL (change from baseline) · chronic rhinosinusitis
2 findings from 1 review
no estimate extracted
Studies not reported
Low
no estimate extracted
Studies not reported
Low
Adverse effects ‐ epistaxis · chronic rhinosinusitis
Topical antifungal showed no clear difference in adverse effects ‐ epistaxis compared with placebo/no treatment (low certainty).
1 finding from 1 review
RR 0.97 [0.14, 6.63]
Studies not reported
Low
Adverse effects: headache · chronic rhinosinusitis
It is very uncertain whether topical antifungal changes adverse effects ‐ headache compared with placebo/no treatment (very low certainty).
1 finding from 1 review
RR 1.26 [0.6, 2.63]
Studies not reported
Very low
Other adverse effects: local irritation · chronic rhinosinusitis
Topical antifungal showed no clear difference in adverse effects ‐ local irritation compared with placebo/no treatment (low certainty).
1 finding from 1 review
RR 2.29 [0.61, 8.62]
Studies not reported
Low
Health‐related quality of life (HRQL) · chronic rhinosinusitis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Disease severity score · chronic rhinosinusitis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Tinnitus loudness · patients with subjective idiopathic tinnitus
2 findings from 1 review
Other adverse effects (yes or no) · patients with subjective idiopathic tinnitus
2 findings from 1 review
Change in tinnitus loudness match (range 0 to 5) · patients with subjective idiopathic tinnitus
1 finding from 1 review
Significant adverse events · patients with subjective idiopathic tinnitus
1 finding from 1 review
Tinnitus symptom severity · patients with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Depressive symptoms · patients with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
Betahistine for tinnitus 2018 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found